Science Explorer Back to mapMap

Most cited papers from Peptides International (United States)

What are the most cited papers from Peptides International (United States)?

The most cited paper from Peptides International (United States) is "Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease" (Srikant Rangaraju, Eric B. Dammer, Syed Ali Raza et al., 2018), with 473 citations. Next come "Peptide therapeutics from venom: Current status and potential" (285) and "Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases" (216).

Showing 50 of 58 papers. Every paper with more than 16 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease Srikant Rangaraju, Eric B. Dammer, Syed Ali Raza et al. · Molecular Neurodegeneration Open access 21 May 2018 473
2 Peptide therapeutics from venom: Current status and potential Michael W. Pennington, Andrzej A. Czerwiński, Raymond S. Norton · Bioorganic & Medicinal Chemistry Open access 23 Sep 2017 285
3 Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases Victor Chi, Michael W. Pennington, Raymond S. Norton et al. · Toxicon Open access 15 Aug 2011 216
4 Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor M.L. Flinspach, Qiaojie Xu, Andrew D. Piekarz et al. · Scientific Reports Open access 3 Jan 2017 124
5 Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease Eric J. Tarcha et al. · Journal of Pharmacology and Experimental Therapeutics Open access 26 May 2012 118
6 Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: A prospective double‐blind trial Robert B. Chinnapongse, Kristen L. Gullo, Paul R. Nemeth et al. · Movement Disorders Sep 2011 106
7 Analogs of the Sea Anemone Potassium Channel Blocker ShK for the Treatment of Autoimmune Diseases Christine Beeton, Michael W. Pennington, Raymond S. Norton · Inflammation & Allergy - Drug Targets Open access Oct 2011 100
8 Kv1.3 channel‐blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases Sandeep Chhabra et al. · The FASEB Journal Open access 2 Jun 2014 92
9 A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation Srikant Rangaraju, Syed Ali Raza, Andrea Pennati et al. · Journal of Neuroinflammation Open access 26 Jun 2017 88
10 A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases Harunur Rashid, Redwan Huq, Mark R. Tanner et al. · Scientific Reports Open access 28 Mar 2014 82
11 Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease Stuart Isaacson, Mark Lew, William G. Ondo et al. · Movement Disorders Clinical Practice Open access 25 May 2016 79
12 Blockade of Kv1.3 channels ameliorates radiation-induced brain injury Ying Peng, Kui Lu, Zichen Li et al. · Neuro-Oncology Open access 4 Dec 2013 78
13 Intranasal Drug Delivery of Olanzapine-Loaded Chitosan Nanoparticles Sarah Baltzley, Mohammad Atiquzzaman, Ahmad H. Malkawi et al. · AAPS PharmSciTech Open access 20 Aug 2014 78
14 FITC-Conjugated Cyclic RGD Peptides as Fluorescent Probes for Staining Integrin αvβ3/αvβ5 in Tumor Tissues Yumin Zheng, Shundong Ji, Andrzej A. Czerwiński et al. · Bioconjugate Chemistry Open access 13 Oct 2014 77
15 Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog Mark R. Tanner, Rajeev B. Tajhya, Redwan Huq et al. · Clinical Immunology Open access 4 Apr 2017 75
16 A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal Charles W. Gorodetzky, SHARON L. WALSH, Peter Martin et al. · Drug and Alcohol Dependence Open access 10 May 2017 72
17 Development of Highly Selective Kv1.3-Blocking Peptides Based on the Sea Anemone Peptide ShK Michael W. Pennington, Shih Yu Chang, Satendra S. Chauhan et al. · Marine Drugs Open access 16 Jan 2015 71
18 Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults Stuart Isaacson, William G. Ondo, Carlayne E. Jackson et al. · JAMA Neurology Open access 13 Jan 2020 70
19 Blocking KV1.3 Channels Inhibits Th2 Lymphocyte Function and Treats a Rat Model of Asthma Shyny Koshy, Redwan Huq, Mark R. Tanner et al. · Journal of Biological Chemistry Open access 19 Mar 2014 70
20 A Potent and Selective Peptide Blocker of the Kv1.3 Channel: Prediction from Free-Energy Simulations and Experimental Confirmation M. Harunur Rashid, Germano Heinzelmann, Redwan Huq et al. · PLoS ONE Open access 7 Nov 2013 68
21 The effect of obestatin on porcine ovarian granulosa cells Monika Mészárosová, Alexander V. Sirotkin, R. Grossmann et al. · Animal Reproduction Science 28 Aug 2007 60
22 Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes Shyny Koshy, Danli Wu, Xueyou Hu et al. · PLoS ONE Open access 11 Oct 2013 58
23 Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine Sunita Gulati, Michael W. Pennington, Andrzej A. Czerwiński et al. · mBio Open access 5 Nov 2019 57
24 Total Synthesis of Human Hepcidin through Regioselective Disulfide‐Bond Formation by using the Safety‐Catch Cysteine Protecting Group 4,4′‐Dimethylsulfinylbenzhydryl Zoltan Dekan, Mehdi Mobli, Michael W. Pennington et al. · Angewandte Chemie International Edition 7 Feb 2014 54
25 Effects of chronic food restriction and treatments with leptin or ghrelin on different reproductive parameters of male rats Alexander V. Sirotkin, Maria Chrenkova, Soňa Nitrayová et al. · Peptides 25 Mar 2008 44
26 99mTc-Galacto-RGD2: A Novel 99mTc-Labeled Cyclic RGD Peptide Dimer Useful for Tumor Imaging Shundong Ji, Andrzej A. Czerwiński, Yang Zhou et al. · Molecular Pharmaceutics Open access 22 Jul 2013 43
27 A C‐terminally amidated analogue of ShK is a potent and selective blocker of the voltage‐gated potassium channel Kv1.3 Michael W. Pennington, M. Harunur Rashid, Rajeev B. Tajhya et al. · FEBS Letters Open access 9 Oct 2012 41
28 Facile preparation of disulfide‐bridged peptides using the polymer‐supported oxidant CLEAR‐OXTM* Krzysztof Darłak, DeAnna Wiegandt Long, Andrzej A. Czerwiński et al. · Journal of Peptide Research Mar 2004 41
29 Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection Robert A. Hauser, Stuart Isaacson, Thomas Clinch · Parkinsonism & Related Disorders 27 Aug 2014 38
30 Psychometric evaluation of the 10-item Short Opiate Withdrawal Scale-Gossop (SOWS-Gossop) in patients undergoing opioid detoxification Margaret Vernon, Stefan Reinders, Sally Mannix et al. · Addictive Behaviors 3 Apr 2016 35
31 Involvement of the transcription factor STAT1 in the regulation of porcine ovarian granulosa cell functions treated and not treated with ghrelin Andrej Benčo, Alexander V. Sirotkin, Dušan Vašíček et al. · Reproduction Open access 15 Jun 2009 35
32 Pulmonary Delivery of the Kv1.3-Blocking Peptide HsTX1[R14A] for the Treatment of Autoimmune Diseases Liang Jin, Qi Tony Zhou, Hak‐Kim Chan et al. · Journal of Pharmaceutical Sciences Open access 12 Jan 2016 32
33 Role of ghrelin in regulating rabbit ovarian function and the response to LH and IGF-I Alexander V. Sirotkin, J. Rafay, J. Kotwica et al. · Domestic Animal Endocrinology 23 Jan 2009 32
34 N‐terminally extended analogues of the K+channel toxin fromStichodactyla helianthusas potent and selective blockers of the voltage‐gated potassium channel Kv1.3 Shih‐Chung Chang, Redwan Huq, Sandeep Chhabra et al. · FEBS Journal Open access 9 Apr 2015 31
35 Buccal mucosal delivery of a potent peptide leads to therapeutically-relevant plasma concentrations for the treatment of autoimmune diseases Liang Jin, Ben J. Boyd, Paul James White et al. · Journal of Controlled Release 4 Dec 2014 31
36 Structure, folding and stability of a minimal homologue from Anemonia sulcata of the sea anemone potassium channel blocker ShK Bankala Krishnarjuna, Christopher A. MacRaild, Punnepalli Sunanda et al. · Peptides Open access 12 Oct 2017 30
37 Synthesis, folding, structure and activity of a predicted peptide from the sea anemone Oulactis sp. with an ShKT fold Bankala Krishnarjuna, Jessica Villegas‐Moreno, Michela L. Mitchell et al. · Toxicon Open access 19 May 2018 29
38 Targeting KCa1.1 Channels with a Scorpion Venom Peptide for the Therapy of Rat Models of Rheumatoid Arthritis Mark R. Tanner, Michael W. Pennington, Brayden H. Chamberlain et al. · Journal of Pharmacology and Experimental Therapeutics Open access 16 Feb 2018 28
39 The anti-microbial peptide TP359 attenuates inflammation in human lung cells infected with Pseudomonas aeruginosa via TLR5 and MAPK pathways Ejovwoke F. Dosunmu, Robert O. Emeh, Saurabh Dixit et al. · PLoS ONE Open access 3 May 2017 28
40 Immunogenicity and Long-Term Efficacy of Botulinum Toxin Type B in the Treatment of Cervical Dystonia Robert B. Chinnapongse, Mark Lew, Joaquim José Ferreira et al. · Clinical Neuropharmacology 29 Aug 2012 28
41 Modulation of Lymphocyte Potassium Channel KV1.3 by Membrane-Penetrating, Joint-Targeting Immunomodulatory Plant Defensin Seow Theng Ong et al. · ACS Pharmacology & Translational Science Open access 14 May 2020 27
42 Food restriction, ghrelin, its antagonist and obestatin control expression of ghrelin and its receptor in chicken hypothalamus and ovary Alexander V. Sirotkin, Silvia Pavlová, Manuel Tena‐Sempere et al. · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology Aug 2012 27
43 Distribution and kinetics of the Kv1.3-blocking peptide HsTX1[R14A] in experimental rats Ralf Bergmann, Manja Kubeil, Kristof Zarschler et al. · Scientific Reports Open access 12 Jun 2017 26
44 Some endocrine traits of transgenic rabbits. II. Changes in hormone secretion and response of isolated ovarian tissue to FSH and ghrelin Alexander V. Sirotkin, Peter Chrenek, Krzysztof Darłak et al. · Physiological Research Open access 2008 26
45 Combinatorial libraries by portioning and mixing. Árpád Furka, Bennett Wd · PubMed Apr 1999 25
46 Identification, chemical synthesis, structure, and function of a new KV1 channel blocking peptide from Oulactis sp. Punnepalli Sunanda, Bankala Krishnarjuna, Steve Peigneur et al. · Peptide Science 24 May 2018 24
47 Synthesis, Chemical Characterization and Multiscale Biological Evaluation of a Dimeric-cRGD Peptide for Targeted Imaging of α V β 3 Integrin Activity Jamila Hedhli, Andrzej A. Czerwiński, Matthew J. Schuelke et al. · Scientific Reports Open access 5 Jun 2017 24
48 KCa1.1 channels regulate β 1 ‐integrin function and cell adhesion in rheumatoid arthritis fibroblast‐like synoviocytes Mark R. Tanner, Michael W. Pennington, Teresina Laragione et al. · The FASEB Journal Open access 20 Apr 2017 24
49 KCa1.1 and Kv1.3 channels regulate the interactions between fibroblast-like synoviocytes and T lymphocytes during rheumatoid arthritis Mark R. Tanner, Michael W. Pennington, Satendra S. Chauhan et al. · Arthritis Research & Therapy Open access 7 Jan 2019 23
50 Expression and isotopic labelling of the potassium channel blocker ShK toxin as a thioredoxin fusion protein in bacteria Shih Chieh Chang, Charles A. Galea, Eleanor W. W. Leung et al. · Toxicon Open access 31 May 2012 22

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.